National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Case
No judgment structure available for this case.

STATUTORY RULES

1972 No.

________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1971.*

WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1971 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1971, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1971.

Dated this ninth day of March, 1972.

Governor-General.

By His Excellency’s Command,

Minister of State for Health.

_____

Amendments of the National Health (Pharmaceutical Benefits) Regulations

Commencement.

1. These Regulations shall come into operation on the first day of April, 1972.

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:

FIRST SCHEDULE Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits

1. Acetomenaphthone

2. Acetomenaphthone Tablets

3. Acetrizoic Acid

4. Alcohol Dehydrated

5. Alcohol (95%)

6. Allopurinol

7. Aloes

8. Almond Oil

9. Aluminium Hydroxide Tablets

10. Amethocaine Hydrochloride

11. Amitriptyline Injection

12. Amodiaquine Tablets

13. Amphetamine Sulphate

14. Amphetamine Sulphate Tablets

_________________________________________________________________________________________________

* Notified in the Commonwealth Gazette on                                                                     1972.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; and 1971, Nos. 44, 101, 136 and 154.

11464/72—Price 30c  9/3.3.1972

15. Amylobarbitone Sodium Tablets

16. Antazoline Hydrochloride

17. Antazoline Tablets

18. Antimony Sodium Tartrate

19. Antimony Sodium Tartrate Injection

20. Apomorphine Hydrochloride

21. Apomorphine Injection

22. Arachis Oil

23. Aspirin Phenacetin and Codeine Tablets

24. Aspirin Phenacetin and Codeine Tablets Soluble

25. Azathioprine

26. Bacillus Calmette-Guérin Vaccine

27. Barium Sulphate

28. Beclomethasone Dipropionate

29. Belladonna Herb

30. Belladonna Herb, Powdered

31. Bemegride

32. Bendrofluazide

33. Bemgride Injection

34. Benzhexol Hydrochloride

35. Benzyl Alcohol

36. Betamethasone Sodium Phosphate Tablets

37. Bethanidine Sulphate

38. Bisacodyl

39. Bisacodyl Suppositories

40. Bisacodyl Tablets

41. Botulinum Antitoxin

42. Bupivacaine Hydrochloride

43. Busulphan

44. Butobarbitone

45. Butylated Hydroxyanisole

46. Butylated Hydroxytoluene

47. Caffeine Hydrate

48. Calciferol Solution

49. Calcium Cyclamate

50. Camphor

51. Caramiphen Hydrochloride

52. Caramiphen Tablets

53. Caraway

54. Carbimazole

55. Carbon Dioxide

56. Carbromal

57. Carbromal Tablets

58. Cardamom Fruit

59. Cascara

60. Catgut, Sterilised, Surgical

61. Cellulose, Oxidised

62. Cetylpyridinium Chloride

63. Chlorambucil

64. Chlordiazepoxide Capsules

65. Chlordiazepoxide Hydrochloride

66. Chlorhexidine Gluconate Solution

67. Chlorhexidine Hydrochloride

68. Chloroform

69. Chlormadinone Acetate

70. Chloroquine Phosphate

71. Chloroquine Phosphate Injection

72. Chloroquine Sulphate

73. Chlorothiazide

74. Chlorotrianisene

75. Chlorotrianisene Capsules

76. Chlorphenesin

77. Chlorproguanil Hydrochloride

78. Chlorproguanil Tablets

79. Chlorpropamide

80. Chlortetracycline Hydrochloride

 

81. Chlorthalidone

82. Cholera Vaccine Mixed

83. Choline Theophyllinate Tablets

84. Cinchocaine Hydrochloride

85. Cinnamon

86. Clofibrate

87. Cochineal

88. Colchicine

89. Colchicum Corm

90. Colchicum Liquid Extract

91. Colchicum Tincture

92. Colistin Tablets

93. Colophony

94. Concentrated Peppermint Water

95. Coriander

96. Coriander Oil

97. Corticotrophin

98. Corticotrophin Injection

99. Corticotrophin Gelatin Injection

100. Corticotrophin Zinc Hydroxide Injection

101. Cortisone Acetate

102. Cottonseed Oil

103. Cresol

104. Cresol and Soap Solution

105. Crotamiton

106. Cyanocobalamin

107. Cyanocobalamin (57 Co)

108. Cyanocobalamin (58 Co)

109. Cyclamic Acid

110. Cyclizine Tablets

111. Cyclobarbitone Calcium

112. Cyclomethycaine Sulphate

113. Cyclopenthiazide

114. Cyclopentolate Hydrochloride

115. Cyclopropane

116. Cycloserine

117. Cycloserine Tablets

118. Dapsone

119. Dequalinium Acetate

120. Dequalinium Chloride

121. Desipramine Hydrochloride

122. Dexamphetamine Sulphate

123. Dexamphetamine Tablets

124. Dextran 110 Injection

125. Dextromethorphan Hydrobromide

126. Dextromethorphan Tablets

127. Dextropropoxyphene Capsules

128. Dextropropoxyphene Hydrochloride

129. Dextropropoxyphene Napsylate

130. Dextrose Monohydrate

131. Diamorphine Hydrochloride

132. Diamorphine Injection

133. Diazepam Capsules

134. Dibromopropamidine Isethionate

135. Dichloralphenazone

136. Dichlorophen

137. Dichlorphenamide

138. Diethylcarbamazine Citrate

139. Diethylcarbamazine Tablets

140. Digitalis Leaf

141. Digitalis Prepared

142. Digitoxin

143. Digitoxin Tablets

144. Dihydrocodeine Injection

145. Dihydrocodeine Tablets

146. Diloxanide Furoate

147. Dilute Alcohols

 

First Schedule—continued

148. Dimenhydrinate

149. Dimenhydrinate Injection

150. Dimenhydrinate Tablets

151. Dimercaprol

152. Dimethisterone

153. Dimethisterone Tablets

154. Diodone Injection

155. Diphtheria and Pertussis Vaccine

156. Diphtheria, Tetanus and Poliomyelitis Vaccine

157. Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine

158. Dipipanone Hydrochloride

159. Dipipanone Injection

160. Dodecyl Gallate

161. Domiphen Bromide

162. Dried Human Albumin

163. Dusting Powder Absorbable

164. Edrophonium Chloride

165. Edrophonium Injection

166. Eltor Vaccine

167. Emetine and Bismuth Iodide

168. Emetine Hydrochloride

169. Erythromycin

170. Ethacrynic Acid

171. Ethchlorvynol

172. Ether Anaesthetic

173. Ethinyloestradiol

174. Ethionamide

175. Ethisterone

176. Ethopropazine Hydrochloride

177. Ethotoin

178. Ethyl Chloride

179. Ethyl Oleate

180. Ethylenediamine Hydrate

181. Eucalyptus Oil

182. Ethynodiol Diacetate

183. Eugenol

184. Ferric Citrate (50 Fe) Injection

185. Ferrous Fumarate

186. Ferrous Succinate Tablets

187. Fludrocortisone Acetate

188. Fluoxymesterone

189. Gallamine Triethiodide

190. Gallamine Injection

191. Gamma Benzene Hexachloride

192. Gelatin Sponge, Absorbable

193. Gentian

194. Gentian Tincture, Compound

195. Ginger

196. Gold (108 Au) Injection

197. Halothane

198. Helium

199. Heparin

200. Hexachlorophane

201. Hexylresorcinol

202. Histamine Acid Phosphate

203. Histamine Acid Phosphate Injection

204. Human Albumin

205. Human Blood, Whole

206. Human Red Blood Corpuscles, Concentrated

207. Human Fibrin Foam

208. Human Fibrinogen

209. Human Normal Gamma Globulin Injection

210. Human Plasma, Dried

211. Human Plasma Protein Fraction

212. Human Plasma Protein Fraction, Dried

213. Human Serum, Dried

214. Human Thrombin

215. Hydrochlorothiazide

216. Hydrocortisone Hydrogen Succinate

217. Hydroflumethiazide

218. Hydrogen Peroxide Solution, Strong

219. Hydroxocobalamin

220. Hydroxychloroquine Sulphate

221. Hyoscine Injection

222. Hyoscine Eye Ointment

223. Hyoscine Tablets

224. Hyoscyamus

225. Hyoscyamus Dry Extract

226. Indigo Carmine

227. Influenza Vaccine

228. Industrial Methylated Spirit

229. Inulin

230. Inulin Injection

231. Iodinated (131 I) Human Serum Albumin Injection

232. Iodipamide Meglumine Injection

233. Iodised Oil Fluid Injection

234. Iopanoic Acid

235. Iopanoic Acid Tablets

236. Iophendylate Injection

237. Iothalamic Acid

238. Ipecacuanha, Prepared

239. Isocarboxazid

240. Isocarboxazid Tablets

241. Isoniazid

242. Isopropyl Alcohol

243. Kaolin, Heavy

244. Laevulose

245. Lemon Peel, Dried

246. Levallorphan Injection

247. Levorphanol Injection

248. Levorphanol Tablets

249. Levorphanol Tartrate

250. Lignocaine and Adrenaline Injection

251. Liothyronine Sodium

252. Liquorice

253. Lithium Carbonate

254. Lucanthone Hydrochloride

255. Lucanthone Tablets

256. Lynoestrenol

257. Magnesium Stearate

258. Maize Oil

259. Male Fern

260. Male Fern Extract

261. Maleic Acid

262. Measles Vaccine (Inactivated)

263. Measles Vaccine (Live Attenuated)

264. Mecamylamine Hydrochloride

265. Mefenamic Acid

266. Mefenamic Acid Capsules

267. Megestrol Acetate

268. Meglumine Iothalamate Injection

269. Melarsoprol

270. Melarsoprol Injection

271. Mepacrine Hydrochloride

272. Mephentermine Sulphate

273. Meprobamate

274. Meprobamate Tablets

275. Mepyramine Injection

276. Mepyramine Maleate

277. Mepyramine Tablets

278. Mercaptopurine

First Schedule—continued

279. Mersalyl Acid

280. Mestranol

281. Metaraminol Tartrate

282. Methadone Hydrochloride

283. Methandienone

284. Methicillin Sodium

285. Methohexitone Injection

286. Methoin

287. Methoserpidine

288. Methoserpidine Tablets

289. Methoxyflurane

290. Methyl Hydroxybenzoate

291. Methylamphetamine Hydrochloride

292. Methylamphetamine Injection

293. Methylamphetamine Tablets

294. Methyldopa

295. Methylergometrine Maleate

296. Methylprednisolone Tablets

297. Methylthiouracil

298. Methylthiouracil Tablets

299. Methyprylone

300. Methyprylone Tablets

301. Metronidazole

302. Morphine Sulphate Tablets

303. Nalorphine Hydrobromide

304. Nandrolone Decanoate

305. Nandrolone Phenylpropionate

306. Naphazoline Hydrochloride

307. Nealbarbitone

308. Nealbarbitone Tablets

309. Neostigmine Bromide

310. Nialamide

311. Nialamide Tablets

312. Niclosamide

313. Nicotinic Acid

314. Nicoumalone

315. Nikethamide

316. Nikethamide Injection

317. Nitrous Oxide

318. Norethandrolone

319. Norethandrolone Tablets

320. Norethisterone

321. Norethynodrel

322. Noscapine

323. Novobiocin Calcium

324. Novobiocin Sodium

325. Novobiocin Tablets

326. Nux Vomica

327. Octyl Gallate

328. Oestradiol Benzoate

329. Olive Oil

330. Opium

331. Opium, Powdered

332. Orange Peel, Dried Bitter

333. Orphenadrine Hydrochloride

334. Oxygen

335. Oxyphenbutazone

336. Oxyphenbutazone Tablets

337. Oxyphencyclimine Hydrochloride

338. Oxytetracycline Tablets

339. Oxytocin Tablets

340. Paramethadione

341. Paramomycin Capsules

342. Paramomycin Sulphate

343. Pempidine Tartarate

344. Penicillamine

345. Penicillamine Hydrochloride

346. Pentamidine Isethionate

347. Pentamidine Injection

348. Pentolinium Tartrate Tablets

349. Peppermint Oil

350. Percutaneous Bacillus Calmette-Guérin Vaccine

351. Perphenazine

352. Perphenazine Tablets

353. Pethidine Tablets

354. Phenacetin

355. Phenazocine Hydrobromide

356. Phenazocine Injection

357. Phenazocine Tablets

358. Phenelzine Sulphate

359. Phenelzine Tablets

360. Phenindamine Tartrate

361. Phenindione

362. Phenmetrazine Hydrochloride

363. Phenmetrazine Tablets

364. Phenolphthalein Tablets

365. Phenolsulphonphthalein

366. Phenoxybenzamine Capsules

367. Phenoxybenzamine Hydrochloride

368. Phenoxymethylpenicillin

369. Phenoxymethylpenicillin Potassium

370. Phentolamine Mesylate

371. Phentolamine Injection

372. Phosphoric Acid

373. Phytomenadione Capsules

374. Phytomenadione Tablets

375. Piperazine Citrate

376. Piperazine Phosphate Tablets

377. Poldine Methylsulphate

378. Poldine Tablets

379. Poliomyelitis Vaccine (Inactivated)

380. Poliomyelitis Vaccine (Oral)

381. Potassium Bromide

382. Potassium Chloride Injection

383. Potassium Hydroxide

384. Potassium Nitrate

385. Prednisolone Pivalate Injection

386. Prednisone Acetate

387. Primaquine Phosphate

388. Probenecid

389. Procainamide Tablets

390. Procaine and Adrenaline Injection

391. Prochlorperazine Maleate

392. Prochlorperazine Mesylate

393. Procyclidine Hydrochloride

394. Progesterone

395. Proguanil Hydrochloride

396. Promazine Hydrochloride

397. Promazine Injection

398. Promazine Tablets

399. Promethazine Theoclate

400. Propranolol Hydrochloride

401. Propyl Gallate

402. Propyliodone

403. Propyliodone Injection

404. Propyliodone Oily Injection

405. Propylthiouracil

406. Pyrazinamide

407. Pyridostigmine Bromide

408. Pyrimethamine

409. Pyroxylin

410. Quillaia

411. Quinine Dihydrochloride

412. Quinine Dihydrochloride Injection

413. Rabies Antiserum

First Schedule—continued

414. Rabies Vaccine

415. Sesame Oil

416. Silver Nitrate, Toughened

417. Soda Lime

418. Sodium Acetate

419. Sodium Acetrizoate Injection

420. Sodium Antimonylgluconate

421. Sodium Antimonylgluconate Injection

422. Sodium Aurothiomalate

423. Sodium Bicarbonate Compound Tablets

424. Sodium Bromide

425. Sodium Calciumedetate

426. Sodium Chromate (51 Cr) Solution

427. Sodium Citrate Tablets

428. Sodium Cyclamate

429. Sodium Diatrizoate

430. Sodium Diatrizoate Injection

431. Sodium Fluoride

432. Sodium Fusidate Capsules

433. Sodium Hydroxide

434. Sodium Iodide (131 I) Injection

435. Sodium Iodide (125 I) Solution

436. Sodium Iodide (131 I) Solution

437. Sodium Iodohippurate (131 I) Injection

438. Sodium Iothalamate Injection

439. Sodium Lauryl Sulphate

440. Sodium Phosphate (32 P) Injection

441. Sodium Stibogluconate

442. Sodium Stibogluconate Injection

443. Solapsone

444. Solapsone Tablets

445. Spironolactone

446. Staphylococcus Antitoxin

447. Stibophen

448. Stibophen Injection

449. Stramonium

450. Sulphadiazine Sodium

451. Sulphadimethoxine

452. Sulphadimidine Injection

453. Sulphadimidine Sodium

454. Sulphamethizole

455. Sulphamethoxydiazine

456. Sulphamethoxypridazine

457. Sulphapyridine

458. Sulphinpyrazone

459. Sulphobromophthalein Sodium

460. Sulphomyxin Injection

461. Sulphomyxin Sodium

462. Sulthiame

463. Suramin

464. Suramin Injection

465. Suxamethonium Chloride

466. Suxamethonium Bromide

467. Suxamethonium Chloride Injection

468. Testosterone

469. Testosterone Phenylpropionate Injection

470. Tetanus and Pertussis Vaccine

471. Tetanus Vaccine (Alum Precipitated)

472. Tetanus Vaccine (Simple Solution)

473. Tetrachloroethylene

474. Tetrachloroethylene Capsules

475. Tetracycline Tablets

476. Thiomersal

477. Thiopentone Sodium

478. Thiopentone Injection

479. Thioridazine Hydrochloride

480. Thyroid

481. Thyroxine Sodium

482. Tolnaftate

483. Tolazoline Hydrochloride

484. Tolazoline Tablets

485. Tolbutamide

486. Tolu Balsam

487. Tranylcypromine Sulphate

488. Tranylcypromine Tablets

489. Triamterene Capsules

490. Trichloroethylene

491. Tricyclamol Chloride

492. Tricyclamol Tablets

493. Tryparsamide

494. Tryparsamide Injection

495. Tuberculin, Old

496. Tuberculin Purified Protein Derivative

497. Tubocurarine Chloride

498. Tubocurarine Injection

499. Turpentine Oil

500. Typhoid-Paratyphoid A and B

501. Typhoid-Paratyphoid A and B and Cholera Vaccine

502. Typhoid-Paratyphoid A and B and Tetanus Vaccine

503. Typhoid-Paratyphoid A, B and C Vaccine

504. Undecenoic Acid

505. Urea

506. Urea Injection

507. Vancomycin Hydrochloride

508. Vancomycin Injection

509. Vinyl Ether

510. Vitamin A Ester Concentrate

511. Yellow Fever Vaccine

512. Zinc Undecenoate

513. Zinc Undecenoate Ointment

 

________________

SECOND SCHEDULE Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

1

Acepifylline .............................................................

—

2

Acetylsulphafurazole..............................................

—

3

Acetylcysteine..........................................................

—

4

Acrylic Resin............................................................

—

5

Adrenaline Hydrochloride......................................

—

6

Albumaid XP............................................................

—

7

Aluminium Sodium Silicate...................................

—

8

Amino Acids.............................................................

Amino Acids with Sorbitol

Amino Acids with Sorbitol and Alcohol

9

Aminogran................................................................

—

10

Amphotericin B........................................................

Tetracycline, B.P.C. with buffering agent and Amphotericin B

11

Ampicillin..................................................................

—

12

Ampicillin Trihydrate.............................................

—

13

Antazoline Sulphate................................................

Naphazoline Nitrate with Antazoline Sulphate

14

Ascorbic Acid...........................................................

Vitamin A with Thiamine Hydrochloride, Riboflavine Nicotinamide, Vitamin D and Ascorbic Acid

Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary

Ferrous Sulphate mixture Prescribers List

Ferrous Sulphate mixture Prescribers List Children’s Section

15

Attapulgite.................................................................

Dihydrostreptomycin Sulphate with Pectin, Dried Aluminium Hydroxide Gel and Attapulgite

16

Bacitracin..................................................................

Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin

17

Bacitracin Zinc.........................................................

Neomycin Undecenoate with Bacitracin Zinc

Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc

18

Belladonna Herb, Prepared....................................

Phenobarbitone with Belladonna Herb, Prepared

19

Belladonna, Dry Extract.........................................

Phenolphthalein with Aloin, Strychnine, B.P.C. 1959, Ipecacuanha and Dry Extract of Belladonna

20

Betamethasone........................................................

Betamethasone Acetate with Betamethasone

21

Betamethasone Acetate..........................................

Betamethasone with Betamethasone Acetate

22

Betamethasone Sodium Phosphate......................

—

23

Betamethasone Phosphate.....................................

—

24

Betamethasone Valerate........................................

Clioquinol with Betamethasone Valerate

25

Brompheniramine Maleate....................................

—

26

Calciferol...................................................................

—

27

Calcium Di-Oxytetracycline..................................

—

28

 

Capsicum Oleoresin.................................................

 

Cascara Dry Extract with Phenolphthalein, Sodium Tauroglycocholate, B.P.C. 1954 and Capsicum Oleoresin

29

Carbachol..................................................................

Hypromellose 4500 with Carbachol

30

Carbinoxamine Maleate.........................................

—

31

 

Cascara Dry Extract................................................

 

Phenolphthalein with Capsicum Oleoresin, Sodium Tauroglycocholate, B.P.C. 1954 and Cascara Dry Extract

32

Ceratonia, B.P.C. 1949...........................................

—

33

Chloramine, B.P.C...................................................

—

34

Chloramphenicol.....................................................

Polymyxin B Sulphate with Chloramphenicol Hydrocortisone Acetate with Chloramphenicol

35

Chloramphenicol Palmitate, B.P.C.......................

—

36

Chloramphenicol Stearate......................................

—

37

Chlorhexidine Gluconate.......................................

—

38

Chlorpheniramine Maleate....................................

—

39

Chlorpromazine Hydrochloride.............................

—

40

Choline Theophyllinate..........................................

Guaiphenesin with Choline Theophyllinate

41

Clemizole Tannate..................................................

—

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

42

Clioquinol..................................................................

Betamethasone Valerate with Clioquinol

Flumethasone Pivalate with Clioquinol

43

Colistin Sulphate.....................................................

Neomycin Sulphate with Colistin Sulphate

44

Cortisone Acetate....................................................

—

45

Cyclizine Hydrochloride........................................

Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride

46

Cymogran.................................................................

—

47

Cyproheptadine Hydrochloride

—

48

Danthron...................................................................

Dioctyl Sodium Sulphosuccinate, B.P.C. with Danthron

49

Demecarium Bromide.............................................

—

50

Demethylchlortetracycline Hydrochloride

Nystatin with Demethylchlortetracycline Hydrochloride

51

Dexamethasone.......................................................

Framycetin Sulphate with Gramicidin and Dexamethasone

52

Dexamethasone Metasulphobenzoate

Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate

53

Dexchlorpheniramine Maleate..............................

—

54

Dextrans....................................................................

Dextrose with Dextrans

Sodium Chloride with Dextrans

55

Dextrose Polymer....................................................

—

56

Diazepam..................................................................

—

57

Dichloralphenazone................................................

—

58

Dicyclomine Hydrochloride...................................

Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride

59

Dienoestrol................................................................

—

60

Diethanolamine Fusidate........................................

—

61

Digoxin.......................................................................

—

62

Dihydrocodeine Tartrate........................................

—

63

Dihydrostreptomycin Sulphate, B.P. 1958

Attapulgite with Pectin, Dried Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958

Kaolin with Pectin, Aluminium Hydroxide Gel and Dihydrostreptomycin Sulphate, B.P. 1958

64

Dihydrotachysterol..................................................

—

65

Dimethicone, B.P.C.................................................

—

66

Dioctyl Sodium Sulphosuccinate, B.P.C..............

Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C.

67

Diphenhydramine Hydrochloride

Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride

68

Diphenylpyraline Hydrochloride

—

69

Diphtheria Vaccine..................................................

Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine

70

Doxycycline Hyclate..............................................

—

71

Doxylamine Succinate............................................

Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate

72

Ecothiopate Iodide..................................................

—

73

Ergometrine Maleate..............................................

Oxytocin with Ergometrine Maleate

74

Ergotamine Tartrate................................................

Caffeine with Ergotamine Tartrate

Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate

Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate

Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate

75

Erythromycin Estolate............................................

—

76

Erythromycin Stearate............................................

—

77

Ethosuximide............................................................

—

78

Ferric Hydroxide......................................................

—

79

Ferrous Aminoacetosulphate................................

—

80

Ferrous Succinate....................................................

—

81

Flumethasone Pivalate............................................

Clioquinol with Flumethasone Pivalate

 

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

82

Fluphenazine Hydrochloride

—

83

Framycetin Sulphate...............................................

Light Kaolin with Framycetin Sulphate

Dexamethasone with Framycetin Sulphate and Gramicidin

Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate

84

Galactomin, Formula No. 17

—

85

Galactomin, Formula No. 19

—

86

Glucose Indicator, Blood........................................

—

87

Glucose Indicator, Urine.........................................

—

88

Goat’s Milk, Dehydrated.......................................

—

89

Goat’s Milk...............................................................

—

90

Gramicidin.................................................................

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin

Framycetin Sulphate with Dexamethasone and Gramicidin

Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin

Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin

91

Guaiphenesin, B.P.C................................................

Theophylline with Guaiphenesin, B.P.C.

92

Hydrocortisone.........................................................

Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone

Neomycin Sulphate with Hydrocortisone

Natamycin with Neomycin Sulphate and Hydrocortisone

93

Hydrocortisone Acetate..........................................

Neomycin Sulphate with Hydrocortisone Acetate

Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate

Oxytetracycline Hydrochloride and Hydrocortisone Acetate

Chloramphenicol with Hydrocortisone Acetate

94

Hyoscine Hydrobromide........................................

Hypromellose 4500 with Hyoscine Hydrobromide

Papaveretum with Hyoscine Hydrobromide

Pethidine Hydrochloride with Hyoscine Hydrobromide

Morphine Sulphate with Hyoscine Hydrobromide

95

Idoxuridine................................................................

—

96

Ipecacuanha.............................................................

Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine, B.P.C. 1959 and Ipecacuanha

97

Isoniazid....................................................................

Sodium Aminosalicylate with Isoniazid

98

Isoprenaline Hydrochloride....................................

—

99

Kanamycin Sulphate, B.P.C.

—

100

Lauryl Dimethylbenzyl Ammonium Chloride

‘TERIC’ N8 with Lauryl Dimethylbenzyl Ammonium Chloride

101

Levallorphan Tartrate.............................................

Pethidine Hydrochloride with Levallorphan Tartrate

102

Lignocaine Hydrochloride......................................

Polymyxin B Sulphate with Propylene Glycol and Lignocaine Hydrochloride

103

Lincomycin Hydrochloride....................................

—

104

Locasol......................................................................

—

105

Lofenalac..................................................................

—

106

Lypressin...................................................................

—

107

Magnesium Aluminium Hydroxide

—

108

Magnesium Chloride...............................................

Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride

Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride

109

Magnesium Hydroxide, B.P.C...............................

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine

 

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

109—cont.

Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C.

110

Mebhydrolin Napadisylate, B.P.C.

—

111

Meclastine Hydrogen Fumarate

—

112

Meclozine Hydrochloride.......................................

Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride

113

Meglumine.................................................................

Theophylline with Meglumine

114

Methacycline............................................................

—

115

Methdilazine Hydrochloride

—

116

Methenamine Mandelate........................................

—

117

Minafen.....................................................................

—

118

Morphine Tartrate....................................................

Morphine Tartrate with Tacrine

119

Nalidixic Acid, B.P.C..............................................

—

120

Naphazoline Nitrate.................................................

Naphazoline Nitrate with Antazoline Sulphate

121

Natamycin.................................................................

Neomycin Sulphate with Hydrocortisone and Natamycin

122

Neomycin Sulphate.................................................

Hydrocortisone Acetate with Neomycin Sulphate

Hydrocortisone with Neomycin Sulphate

Colistin Sulphate with Neomycin Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Kaolin with Neomycin Sulphate

Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate

Polymyxin B Sulphate with Hydrocortisone and Neomycin Sulphate

Prednisolone Sodium Phosphate with Neomycin Sulphate

Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate

Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate

Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate

Natamycin with Hydrocortisone and Neomycin Sulphate

123

Neomycin Undecenoate.........................................

Bacitracin Zinc with Neomycin Undecenoate

124

Neostigmine Methylsulphate.................................

—

125

Nicotinamide.............................................................

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D

126

Nitrofurantoin...........................................................

—

127

Noradrenaline Acid Tartrate..................................

—

128

Nortriptyline Hydrochloride...................................

—

129

Nystatin......................................................................

Tetracycline, B.P.C. with a buffering agent and Nystatin

Demethylchlortetracycline with Nystatin

Tetracycline Hydrochloride with Nystatin

Gramicidin with Neomycin Sulphate

Triamcinolone Acetonide and Nystatin

Oxytetracycline Dihydrate with Nystatin

130

Nutramigen................................................................

—

131

Octatropine Methylbromide...................................

—

132

Orciprenaline Sulphate...........................................

—

133

Oxytetracycline Dihydrate.....................................

Nystatin with Oxytetracycline Dihydrate

134

Oxytetracycline Hydrochloride.............................

Polymyxin B Sulphate with Oxytetracycline Hydrochloride

Hydrocortisone Acetate with Oxytetracycline Hydrochloride

135

Oxethazaine..............................................................

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C. and Oxethazaine

136

Oxytocin....................................................................

Ergometrine Maleate with Oxytocin

137

Pancreatin..................................................................

—

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

138

Pancreatin Enzyme, 4 times U.S.N.F.XII strength

 

—

139

Papaveretum, B.P.C................................................

Hyoscine Hydrobromide with Papaveretum, B.P.C.

140

Penicillin, Benethamine, B.P.C.

Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin

141

Penicillin, Benzathine.............................................

Procaine Penicillin with Potassium Penicillin and Benzathine Penicillin

142

Penicillin, Benzyl.....................................................

Procaine Penicillin with Benzyl Penicillin

143

 

Penicillin, Phenoxymethyl (Benzathine, Hydrabamine, or Calcium Salt)

—

 

144

Penicillin, Potassium...............................................

Benzathine Penicillin with Procaine Penicillin and Potassium Penicillin

145

Penicillin, Procaine..................................................

Benethamine Penicillin, B.P.C. with Sodium Penicillin Procaine Penicillin

Benzathine Penicillin with Potassium Penicillin and Procaine Penicillin

Benzyl Penicillin with Procaine Penicillin

146

Penicillin, Sodium...................................................

Procaine Penicillin with Benethamine Penicillin, B.P.C. and Sodium Penicillin

147

Pentobarbitone.........................................................

Barbitone Sodium with Phenobarbitone Sodium and Pentobarbitone

148

Pericyazine................................................................

—

149

Pertussis Vaccine.....................................................

Diphtheria, Tetanus (Purified Toxoid Aluminium Phosphate Adsorbed) and Pertussis Vaccine

150

Pethidine Hydrochloride.........................................

Levallorphan Tartrate with Pethidine Hydrochloride

Hyoscine Hydrobromide with Pethidine Hydrochloride

151

Phenethicillin Potassium........................................

—

152

Pheniramine Maleate..............................................

—

153

Phenytoin, B.P.C......................................................

—

154

Pholcodine.................................................................

—

155

Pipenzolate Methobromide....................................

—

156

Pituitary (Posterior Lobe), Powdered, B.P.C.

—

157

PK AID I...................................................................

—

158

PK AID II..................................................................

—

159

Plasma Substitute (Polypeptide)

—

160

Polyisobutylene........................................................

—

161

Polymyxin B Sulphate............................................

Chloramphenicol with Polymyxin B Sulphate

Oxytetracycline Hydrochloride with Polymyxin B Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Propylene Glycol with Acetic Acid and Polymyxin B Sulphate

Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate

Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate

Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate

162

Polyvinyl Alcohol....................................................

Pilocarpine Nitrate and Polyvinyl Alcohol

163

Prednisolone..............................................................

—

164

Prednisolone Acetate..............................................

Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.

165

Methylprednisolone.................................................

—

166

Prednisolone Sodium Hemisulphate

Sulphaethidole with Prednisolone Sodium Hemisulphate

167

Prednisolone Sodium Phosphate

Neomycin Sulphate with Prednisolone Sodium Phosphate

168

Prednisolone Pivalate..............................................

—

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

169

Primidone...................................................................

—

170

Promethazine Hydrochloride..................................

—

171

Pseudoephedrine Hydrochloride............................

—

172

Pyrantel Embonate..................................................

—

173

Pyridoxine Hydrochloride.......................................

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

174

Prosobee.....................................................................

—

175

Riboflavine................................................................

Vitamin A with Thiamine Hydrochloride, Nicotinamide, Ascorbic Acid, Vitamin D and Riboflavine

176

Salbutamol................................................................

—

177

Senna Fruit.................................................................

—

178

Silver Nitrate, Toughened.......................................

—

179

Similac Isomil...........................................................

—

180

Sobee..........................................................................

—

181

Sodium Acid Citrate................................................

—

182

Sodium Lactate........................................................

Potassium Chloride with Sodium Chloride and Sodium Lactate

Potassium Chloride with Magnesium Chloride, Sodium Chloride and Sodium Lactate

Potassium Chloride with Dextrose and Sodium Lactate

Sodium Chloride with Dextrose and Sodium Lactate

Sodium Chloride with Sodium Lactate

183

Sodium Potassium Tartrate, B.P.C

Compound Effervescent Powder, B.P.C.

184

Sodium Tauroglycocholate, B.P.C. 1954

Cascara Dry Extract with Phenolphthalein, Capsicum Oleoresin and Sodium Tauroglycocholate, B.P.C. 1954

185

Sorbitol.......................................................................

Amino Acids with Sorbitol

Amino Acids with Sorbitol and Alcohol

186

Soyalac......................................................................

—

187

Strychnine, B.P.C. 1959.........................................

Phenolphthalein with Aloin, Dry Extract of Belladonna, Ipecacuanha and Strychnine, B.P.C. 1959

188

Sulphaethidole..........................................................

Prednisolone Sodium Hemisulphate with Sulphaethidole

189

Sulphafurazole.........................................................

—

190

Sulphamethizole......................................................

—

191

Sulphamethoxazole.................................................

Trimethoprim with Sulphamethoxazole

192

Sulphaphenazole, B.P.C.........................................

—

193

Surgical Cement......................................................

—

194

Surgical Cement Solvent........................................

—

195

Tacrine

Morphine Sulphate with Tacrine

Morphine Tartrate with Tacrine

196

‘TERIC’ N8..............................................................

Lauryl Dimethylbenzyl Ammonium Chloride with ‘TERIC’ N8

197

Testosterone Decanoate.........................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

198

Testosterone Isocaproate.......................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

199

Testosterone Phenylpropionate.............................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

200

Testosterone Propionate.........................................

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

201

Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Diphtheria, Pertussis and Tetanus Vaccine (Purified Toxoid Aluminium Phosphate Adsorbed)

Second Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Allowable Compounds (if any)

202

Tetracycline, B.P.C..................................................

Tetracycline, B.P.C. with a buffering agent

Tetracycline, B.P.C. with a buffering agent and Amphotericin B

Tetracycline, B.P.C. with a buffering agent and Nystatin

203

Tetracycline Hydrochloride...................................

Tetracycline Hydrochloride with Nystatin

Procaine Hydrochloride with Tetracycline Hydrochloride

204

Thiamine Hydrochloride........................................

Riboflavine with Nicotinamide, Ascorbic Acid, Vitamin A, Vitamin D and Thiamine Hydrochloride

205

Thioridazine..............................................................

—

206

Thiotepa....................................................................

—

207

Thonzonium Bromide.............................................

Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide

208

Thonzylamine Hydrochloride

Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride

209

Tiemonium Iodide...................................................

—

210

Tragacanth, Indian (Gum Karaya)

—

211

Triamcinolone Acetonide.......................................

Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide

212

Triclofos Sodium.....................................................

—

213

Trifluoperazine Hydrochloride

—

214

Triglyde......................................................................

—

215

Trimeprazine Tartrate, B.P.C.

—

216

Trimethoprim............................................................

Trimethoprim with Sulphamethoxazole

217

Triprolidine Hydrochloride....................................

—

218

Vinyl Acetate...........................................................

Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine

219

Vinyl Pyrrolidone.....................................................

Vinyl Acetate and Vinyl Pyrrolidone with Benzocaine

220

Viprynium Embonate.............................................

—

221

Vitamin A..................................................................

Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin D and Vitamin A

222

Vitamin D..................................................................

Thiamine Hydrochloride with Riboflavine, Nicotinamide, Ascorbic Acid, Vitamin A and Vitamin D

 

_________________

 

THIRD SCHEDULE Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

 

1. Acepifylline

2. Acetazolamide Sodium

3. Acetohexamide

4. Acetylcholine Chloride

5. Acetylcysteine

6. Acetyl Sulphafurazole

7. Acidified Golden Syrup, A.P.F. 1955

8. Acriflavine, B.P.C. 1963

9. Acrylic Resin

10. Adenaline Hydrochloride

11. Adrenaline Mucate

12. Albumaid XP

13. Aldosterone

14. Aloin, B.P.C.

15. Almond Oil Volatile Bitter, B.P.C. 1959

16. Aloxiprin

17. Alprenolol Hydrochloride

18. Aluminium Acetate Solution, B.P.C.

19. Aluminium Hydroxide Mixture, A.P.F.

20. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex

21. Aluminium Sodium Silicate

22. Amantadine Hydrochloride

23. Amaranth Solution, A.P.F.

24. Amaranth Solution, Compound, A.P.F.

25. Amaranth Solution, B.P.C.

26. Ambenonium Chloride

27. Amino Acids

28. Aminocaproic Acid

29. Aminogran

30. Aminosalicylic Acid

31. Amitriptyline Embonate

32. Ammonia Aromatic Spirit, B.P.C.

33. Ammonia Solution, strong, B.P.C.

34. Ammonium Acetate Solution, strong, B.P.C.

35. Ammonium Bicarbonate, B.P.C.

36. Amphotericin B

Third Schedule—continued

37. Angiotensin Amide

38. Antazoline Mesylate, B.P.C.

39. Antazoline Sulphate

40. Anti-Haemophilic Factor of Animal Origin

41. Attapulgite

42. Bacitracin Zinc

43. Belladonna Suppository, B.P. 1948

44. Benzalkonium Chloride

45. Benzoin Compound Tincture, B.P.C.

46. Bephenium Hydroxynaphthoate, B.P.C.

47. Betahistine Hydrochloride

48. Betamethasone Acetate

49. Betamethasone Phosphate

50. Black Snake Antivenene

51. Biperiden Hydrochloride

52. Bismuth Subgallate, B.P.C.

53. Brompheniramine Maleate

54. Brown Snake Antivenene

55. Buchu Concentrated Infusion, B.P.C. 1954

56. Cade Oil, B.P.C.

57. Caffeine and Sodium Benzoate, B.P.C. 1954

58. Caffeine Citrate, B.P.C. 1959

59. Calcium Di-Oxytetracycline

60. Calcium Gluconogalactogluconate

61. Capreomycin Sulphate

62. Capsicum Ointment, B.P.C.

63. Capsicum Oleoresin

64. Carbamazepine

65. Carbenoxolone Sodium

66. Carbinoxamine Maleate

67. Cardamon Aromatic Tincture, B.P.C.

68. Catechu Tincture, B.P.C.

69. Cephalexin Monohydrate

70. Cephalothin Sodium

71. Ceratonia, B.P.C. 1949

72. Cetomacrogol Emulsifying Wax. B.P.C.

73. Charcoal

74. Chloramine, B.P.C.

75. Chloramphenicol Palmitate, B.P.C.

76. Chloramphenicol Stearate

77. Chloramphenicol Succinate

78. Chlorhexidine Acetate

79. Chlorhexidine Gluconate

80. Cholestyramine

81. Clemizole Hydrochloride

82. Clemizole Tannate

83. Clopamide

84. Clorexolone

85. Coal Tar, B.P.C.

86. Coal Tar Solution Strong, B.P.C.

87. Cochineal Tincture, B.P. 1948

88. Coconut Oil, B.P.C. 1949

89. Colophony Ointment, B.P.C. 1959

90. Copper Sulphate, B.P.C.

91. Creosote, B.P.C. 1959

92. Cyclothiazide

93. Cycrimine Hydrochloride

94. Cymogran

95. Cytosine Arabinoside Hydrochloride

96. Danthron

97. Death Adder Antivenene

98. Debrisoquine

99. Demecarium Bromide

100. Desferrioxamine Mesylate

101. Deslanoside

102. Dexamethasone Metasulphobenzoate

103. Dexamethasone Sodium Phosphate

104. Dexchlorpheniramine Maleate

105. Dextrans

106. Dextriferron

107. Dextrose Polymer

108. Diazoxide

109. Dibenzepin Hydrochloride

110. Diethanolamine Fusidate, B.P.C.

111. Diethazine Hydrochloride, B.P. 1963

112. Dihydroergotamine Mesylate

113. Dihydroergotoxin Mesylate

114. Dihydrostreptomycin Sulphate, B.P. 1958

115. Dimethicone, B.P.C.

116. Dimethindene Maleate

117. Dioctyl Sodium Sulphosuccinate, B.P.C.

118. Diphenylpyraline Hydrochloride

119. Diphtheria Vaccine (Purified toxoid alumnium phosphate) diluted

120. Diphtheria and Tetanus Vaccine, Adult

121. Disodium Cromoglycate

122. Doxycycline Hyclate

123. Doxylamine Succinate

124. Droperidol

125. Ephedrine, B.P.C.

126. Epicillin

127. Erythrityl Tetranitrate

128. Erythromycin Ethyl Succinate

129. Erythromycin Glucoheptonate

130. Erythromycin Lactobionate

131. Ethanolamine Oleate

132. Ethoxzolamide

133 Ethylidene Dicoumarin

134. Ethylinoradrenaline Hydrochloride

135. Ethyloestrenol

136. Ferric Hydroxide

137. Ferrous Aminoacetosulphate

138. Ferrous Phosphate Compound, Syrup, B.P.C.

139. Flumethasone Pivalate

140. Fluorouracil Sodium

141. Fluphenazine Decanoate

142. Fluphenazine Enanthate

143. Flurandrenolone Acetonide

144. Framycetin Sulphate

145. Galactomin, Formula No. 17

146. Galactomin, Formula No. 19

147. Gall and Opium Ointment, B.P.C. 1963

148. Gelsemium Tincture, B.P.C.

149. Gentamicin Sulphate

150. Ginger Syrup, B.P.C.

151. Glibenclamide

152. Glucagon Hydrochloride

153. Glucose Indicator—Blood

154. Glucose Indicator—Urine

154. Glycerophosphate Compound Syrup, A.P.F.

156. Glycopyrronium Bromide

157. Glymidine

158. Goat’s Milk, Dehydrated

159. Goat’s Milk, Whole (Sterilised)

160. Gramicidin

161. Guaiphenesin, B.P.C.

162. Hamamelis Liquid Extract, B.P.C.

163. Hexocyclium Methylsulphate

Third Schedule—continued

164. Haemodialysis Fluid—Concentrate

165. Hydrargaphen

166. Hydromorphone Hydrochloride

167. Hydroxyprogesterone

168. Hydroxyurea

169. Hyoscine Butylbromide

170. Hyoscine Methobromide

171. Hypophosphorous Acid, Dilute, B.P.C. 1963

172. Hypromellose 4500

173. Indomethacin

174. Influenza Vaccine—Sub Unit type (Desoxycholate Treated)

175. Injection of Amino Acids with Sorbitol and Alcohol

176. Injection of Casein Hydrolysate with Laevulose and Alcohol

177. Injection of Dextran with Dextrose

178. Injection of Potassium Chloride with Sodium Lactate and Dextrose

179. Injection of Sodium Chloride with Potassium Chloride, Calcium Chloride and Dextrose

180. Injection of Sodium Chloride with Sodium Lactate and Dextrose

181. Insect Allergan Extract—Honey Bee

182. Insect Allergan Extract—Jumper Ant

183. Insect Allergan Extract—Paper Wasp

184. Insulin Injection, specially purified

185. Insulin Isophane Injection, specially purified

186. Insulin Injection, Special P (Pig)

187. Invert Sugar

188. Iron Polymaltose Complex

189. Isoprenaline Hydrochloride

190. Isopropamide Iodide

191. Kanamycin Sulphate, B.P.C.

192. Lactulose

193. Lanatoside-C

194. Lauryl Dimethyl Benzyl Ammonium Chloride

195. Lavender Spike Oil, B.P.C.

196. Lead Subacetate Dilute Solution

197. Lead Subacetate Strong Solution, B.P.C.

198. Levodopa

199. Lemon Oil Terpencless, B.P.C.

200. Lemon Tincture, B.P. 1958

201. Leucovorin

202. Lincomycin Hydrochloride

203. Lipopancreatin

204. Lobelia Ethereal Tincture, B.P.C.

205. Locasol

206. Lofenalac

207. Lypressin

208. Magenta, B.P.C.

209. Magnesium-Aluminium Hydroxide

210. Magnesium Hydroxide, B.P.C.

211. Maphenide Acetate

212. Mebeverine Hydrochloride

213. Mebhydrolin Napadisylate, B.P.C.

214. Meclastine Hydrogen Fumarate

215. Medroxyprogesterone Acetate

216. Melphalan

217. Mepenzolate Bromide

218. Mercaptomerin Sodium

219. Mercuric Chloride, B.P.C.

220. Metaraminol Bitartrate

221. Methacycline

222. Methaqualone Hydrochloride

223. Methdilazine Hydrochloride

224. Methenamine Mandelate

225. Methenolone Acetate

226. Methoxamine Hydrochloride, B.P.C.

227. Methsuximide

228. Methyclothiazide

229. Methylphenobarbitone, B.P.C. 1963

230. Methylprednisolone Acetate

231. Methylprednisolone Sodium Succinate

232. Methysergide Maleate

233. Metyrapone

234. Minafen

235. Minocycline Hydrochloride

236. Morphine Tartrate

237. Myrrh Tincture, B.P.C.

238. Nalidixic Acid, B.P.C.

239. Nandrolone Hexoxyphenyl Propionate

240. Natamycin

241. Neomycin Undecenoate

242. Nitrazepam

243. Nitromin

244. Nutramigen

245. Octatropine Methylbromide

246. Oestradiol Dipropionate, B.P.C. 1954

247. Oestrone, B.P.C. 1954

248. Oily Opthalmic Vehicle, A.P.F. 1955

249. Orange Syrup, B.P.C.

250. Orange Tincture, B.P.C.

251. Oxethazaine

252. Oxprenolol Hydrochloride

253. Oxycodone Pectinate

254. Oxymel, B.P.C.

255. Oxymel of Squill, B.P.C.

256. Oxymetholone

257. Oxyphenonium Bromide

258. Oxytetracycline

259. Oxytocin

260. Pancreatin Enzyme, U.S.N.F. XII

261. Papaveretum, B.P.C.

262. Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955

263. Paraben Ophthalmic Vehicle, A.P.F. 1955

264. Paraffin Liquid Light, B.P.C. 1963

265. Paramethasone Acetate

266. Pectin

267. Penicillinase

268. Penicillin Benethamine, B.P.C.

269. Pentaerythritol Tetranitrate, diluted, B.P.C.

270. Pentazocine Lactate

271. Penthienate Methobromide

272. Pentobarbitone

273. Pericyazine

274. Pericyazine Mesylate

275. Peritoneal Dialysis Solution with Dextrose

276. Phenformin Hydrochloride

277. Pheniramine Maleate

278. Pheniramine Para-Aminosalicylate

279. Phenol Ointment, B.P. 1948

280. Phenoxymethylpenicillin, Benzathine

281. Phenoxymethylpenicillin, Hydrabamine

282. Phensuximide, B.P.C.

283. Phenthimentonium

284. Phenytoin, B.P.C.

285. Phthalylsulphacetamide

286. Physostigmine, B.P.C.

Third Schedule—continued

287. Pilocarpine Hydrochloride

288. Pipenzolate Methobromide

289. Pituitary Hormone, Follicle-stimulating, Human

290. Pituitary Hormone, Growth, Human

291. Pituitary (Posterior Lobe) Powdered, B.P.C.

292. Pizotifen Malate

293. PK AID I

294. PK AID II

295. Plasma Substitute (Polypeptide)

296. Polyisobutylene

297. Polyoestradiol Phosphate

298. Polyvinyl Alcohol

299. Potassium Chlorate, B.P.C.

300. Potassium Effervescent Tablets

301. Potassium Perchlorate

302. Practolol

303. Prednisolone Acetate

304. Prednisolone Sodium Succinate

305. Prednisolone Sodium Hemisulphate

306. Prednisolone Steaglate

307. Prednisolone Tertiary Butyl Acetate

308. Prindolol

309. Procarbazine Hydrochloride

310. Prochlorperazine

311. Proscillaridin

312. Prosobee

313. Protriptyline Hydrochloride

314. Pseudoephedrine Hydrochloride

315. Pumilio Pine Oil, B.P.C.

316. Pyrantel Embonate

317. Pyridine Aldoxime Methiodide

318. Quillaia Tincture, B.P.C.

319. Quinethazone

320. Quinidine Bisulphate

321. Rasberry Syrup, B.P.C.

322. Rauwolfia Alkaloids

323. Rauwolfia Serpentina, B.P.C.

324. Red Back Spider Antivenene

325. Rolitetracyclinc

326. Rosemary Oil, B.P.C.

327. Salbutamol

328. Salicylamide

329. Secbutobarbitone Sodium

330. Senega, Concentrated Infusion, B.P.C. 1968

331. Senna Fruit Extract (Standardised)

332. Siberian Fir Oil, B.P.C. 1949

333. Silver Protein, B.P.C.

334. Silver Protein Mild, B.P.C.

335. Similac Isomil

336. Snake Bite Antivenene—Polyvalent

337. Sobee

338. Sodium Lactate

339. Sodium Lactate Compound Injection, B.P. with Dextrose

340. Sodium Nitroprusside

341. Sodium Potassium Tartrate. B.P.C.

342. Sodium Tauroglycocholate, B.P.C. 1954

343. Sorbide Nitrate

344. Sorbitol

345. Soyalac

346. Spectinomycin Dihydrochloride Pentahydrate

347. Squill Tincture, B.P.C.

348. Stanolone

349. Stanozolol

350. Stearic Acid, B.P.C.

351. Stilboestrol Diphosphate

352. Stone Fish Antivenene

353. Streptokinase

354. Strychnine, B.P.C. 1959

355. Sulphaethidole

356. Sulphamethoxazole

357. Sulphaphenazole, B.P.C.

358. Sulphasalazine

359. Sulphasymazine

360. Sulphurated Potash, B.P.C.

361. Sulphur Sublimed, B.P.C.

362. Surgical Cement

363. Surgical Cement Solvent

364. Tacrine

365. Taipan Antivenene

366. Tartrazine, B.P.C. 1954

367. ‘TERIC’ N8

368. Testosterone Decanoate

369. Testosterone Enanthate

370. Testosterone Isocaproate

371. Tetracosactrin

372. Tetracycline, B.P.C.

373. Thiabendazole

374. Thiethylperazine Malate

375. Thiethylperazine Maleate

376. Thioridazine

377. Thonzonium Bromide

378. Thonzylamine Hydrochloride

379. Thyrotrophin

380. Tiemonium Iodide

381. Tiger Snake Antivenene

382. Titanium Dioxide, B.P.C.

383. Tolazamide

384. Tragacanth, Indian (Gum Karaya)

385. Tragacanth Mucilage

386. Tridihexethyl Chloride

387. Triethanolamine, B.P.C.

388. Triglyde

389. Trimeprazine Tartrate. B.P.C.

390. Trimethoprim

391. Trimipramine Maleate

392. Trolnitrate Phosphate

393. Typhoid Vaccine

394. Vanillin

395. Vasopressin Tannate

396. Vinblastine Sulphate

397. Vincristine Sulphate

398. Vinyl Acetate

399. Vinyl Pyrrolidone

400. Vitamin A

401. Vitamin D

402. Zinc Gelatin, B.P.C.

______________

FOURTH SCHEDULE Regulation 12.

Additives

1. Acetone, B.P.C.

2. Alcohol (95%), B.P.

3. Arachis Oil, B.P.

4. Amethocaine Hydrochloride, B.P.

5. Camphor, B.P.

6. Carmine Solution, A.P.F.

7. Castor Oil, B.P.

8. Citronella Oil, B.P.C.

9. Chlorhexidine Gluconate Solution, B.P.

10. Chloroform, B.P.

11. Concentrated Anise Water, B.P.C.

12. Concentrated Cinnamon Water, B.P.C.

13. Concentrated Peppermint Water, B.P.

14. Dextrose Monohydrate, B.P.

15. Dilute Alcohols, B.P.

16. Ether Anaesthetic, B.P.

17. Eucalyptol, B.P.C.

18. Eucalyptus Oil, B.P.

19. Honey—Purified, B.P.C.

20. Maize Oil, B.P.

21. Olive Oil, B.P.

22. Peppermint Oil, B.P.

23. Sodium Thiosulphate, B.P.C.

24. Solution of Burnt Sugar, B.P.C. 1959

25. Spirit, Methylated, Industrial, B.P.

26. Syrup of Pholcodine Citrate, B.P.C. 1959

27. Turpentine Oil, B.P.

28. Xylene, B.P.C. 1949

______________

FIFTH SCHEDULE Regulation 14.

Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

1

Acetylcysteine.........................................

Cystic Fibrosis (mucoviscidosis)

2

(1) Aspirin with Paracetamol and Caffeine Tablets

Any disease or condition in a pensioner

(2) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets

3

Acrylic Resin...........................................

Ileostomy or colostomy conditions

4

Albumaid XP...........................................

With the written authority of the Director-General, phenylketonuria

5

Aldosterone..............................................

With the written authority of the Director-General, treatment of an acute crisis in adrenal cortical hypofunction (including Addison’s disease, bilateral adrenalectomy and salt-losing congenital adrenal hyperplasia)

6

Alprenolol Hydrochloride Injection

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

7

Alprenolol Hydrochloride Tablets

With the written authority of the Director-General—

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

8

Amantadine Hydrochloride….….….….

With the written authority of the Director-General, the treatment of Parkinson’s disease caused otherwise than by treatment with a drug

9

Aminocaproic Acid….….….….….…...

Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

10

Aminogran..............................................

With the written authority of the Director-General, phenylketonuria

11

Aminosalicylic Acid..............................

Tuberculosis

12

Amphotericin B Injection....................

Systemic mycoses

13

(1) Ampicillin Capsules, B.P.

Infections by susceptible organisms where these cannot be safely and effectively treated with sulphonamides, or any of the following administered orally—benzyl penicillin, phenoxymethyl—penicillin or phenethicillin

(2) Ampicillin Injections, Tablets and Syrups

Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to ampicillin

Urinary tract infections where a patient who is sensitive to sulphonamides

14

Ascorbic Acid Tablets, B.P.

Any disease or condition in a pensioner

15

Azathioprine...........................................

With the written authority of the Director-General, azathioprine therapy for a person who has been discharged from an approved hospital and received that therapy while a patient in the hospital

16

Benzathine Penicillin, B.P....................

Prophylaxis of recurrent streptococcal infections (including rheumatic fever)

17

Benzoin Compound Tincture, B.P.C. aerosol spray

Ileostomy or colostomy conditions

18

Benzylpenicillin Injection, 5,000,000 units

Bacterial endocarditis or septicaemia

19

Benzylpenicillin Injection, 10,000,000 units

Bacterial endocarditis or septicaemia

Gastrointestinal surgery

20

(1) Benzylpenicillin with Streptomycin Sulphate

Endocarditis due to streptococcus faecalis or streptococcus viridans

(2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate

21

Betahistine Hydrochloride...................

Meniere’s syndrome

22

Betamethasone Acetate and

Intra-articular use

Betamethasone Injection

With the written authority of the Director-General, preoperative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy

23

Busulphan Tablets, B.P.

Treatment in malignant neoplasia

24

(1) Calciferol Tablets, Strong, B.P.

Any disease or condition in a pensioner

With the written authority of the Director-General—

(2) Calciferol, B.P.

Hypoparathyroidism

Osteomalacia following gastrectomy

Vitamin D-resistant rickets

25

Calcium Aminosalicylate.....................

Tuberculosis

26

Capreomycin Sulphate.........................

Tuberculosis

27

Carbamazepine......................................

Epilepsy

Trigeminal neuralgia

28

Carbenicillin Sodium............................

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent

29

Carbenoxolone Sodium........................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, gastric ulcer where a radiological examination or other appropriate tests have confirmed the presence of a gastric ulcer

30

Cephalexin Monohydrate....................

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

31

Cephaloridine.........................................

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent

32

Cephalothin Sodium.............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent

33

Ceratonia................................................

Oesophageal reflux in infants

34

Charcoal Tablets...................................

Ileostomy or colostomy conditions

35

Chlorambucil Tablets, B.P...................

Treatment in malignant neoplasia

36

Chloramine Deodorant Tablets and powder

Ileostomy or colostomy conditions

37

(1) Chloramphenicol Capsules, B.P.

Bacterial meningitis

Intraocular infections

(2) Chloramphenicol Injections

Rickettsioses

Typhoid

(3) Chloramphenicol Oral Suspension

The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient

38

Chlorotrianisene Tablets......................

Carcinoma of the prostate

39

(1) Chlorpromazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Chlorpromazine Injection, B.P.

Major psychoses including—

Major organic psychoses

(3) Chlorpromazine Tablets, B.P.

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

40

Cholestyramine.....................................

With the written authority of the Director-General—

Bile salt malabsorption associated with ileal resection or proven ileal disease

Pruritis associated with partial biliary obstruction not responding to other therapy

Initial treatment with cholestyramine of proven hyperbetalipoproteinaemia (type 11) not responding to other therapy

A second or subsequent course of treatment for proven hyperbetalipoproteinaemia (type 11) in patients who respond to treatment with cholestyramine but do not respond to other therapy

41

Clofibrate................................................

With the written authority of the Director-General—

Diabetic retinopathy (exudative)

Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy

A second or subsequent course of treatment for hyperlipidaemia where significant lowering of serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report

42

(1) Cloxacillin Sodium, B.P................

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Cloxacillin Capsules, B.P.

With the written authority of the Director-General, serious infections where bacteriological evidence confirms the presence of penicillinase-producing staphylococci

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

43

(1) Codeine Phosphate with Aspirin Soluble Tablets

Any disease or condition in a pensioner

(2) Codeine Phosphate with Aspirin Tablets

(3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets

(4) Codeine Phosphate with Aspirin and Paracetamol Tablets

(5) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets

44

Colistin Sulphomethate Sodium, B.P., for injection

Pyocyaneus infection, other gram-negative infections where no other drug is effective

45

Cyanocobalamin Injection, B.P.

Pernicious anaemia and other proven Vitamin B-12 deficiencies

Post gastrectomy treatment

Sub-acute combined degeneration of the cord

Neuroblastoma

46

Cycloserine Capsules, B.P....................

Tuberculosis

47

Cymogran...............................................

With the written authority of the Director-General, phenylketonuria

48

(1) Cyproheptadine Hydrochloride, B.P.

Allergic rhinitis

Allergic dermatoses

(2) Cyproheptadine Tablets, B.P.

Migraine

49

Cytosine Arabinoside Hydrochloride

Any disease or condition in a patient receiving treatment in or at an approved hospital

50

Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and ‘TERIC’ N8)

Ileostomy or colostomy conditions

51

(1) Deoxycortone Acetate Injection, B.P.

Adrenal cortical hypofunction (including Addison’s disease, bilateral adrenalectomy and salt-losing congenital adrenal hyperplasia)

(2) Deoxycortone Acetate Implants, B.P.

(3) Deoxycortone Acetate, B.P.

52

Desferrioxamine Mesylate...................

Acute iron poisoning

Hepatolenticular degeneration

53

(1) Dextromoramide Tablets, B.P.

Treatment in malignant neoplasia

(2) Dextromoramide Tartrate, B.P.

54

Dextrose Polymer..................................

With the written authority of the Director-General, phenylketonuria

55

(1) Diazepam, B.P., Syrup....................

Any disease or condition in a pensioner

(2) Diazepam Tablets, B.P....................

Any disease or condition in a patient receiving treatment in or at an approved hospital

The treatment of a mental disorder in a patient discharged from an approved hospital at which he received treatment for a mental disorder

Epilepsy

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Motor neurone lesion

Multiple sclerosis

Radiation sickness

Stiff-man syndrome

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

56

Diazoxide................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

57

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

Vomiting in pregnancy

58

Dienoestrol Cream................................

Any disease or condition in a pensioner

59

(1) Dihydroergotoxine Mesylate Tablets

For the treatment of patients who have suffered an attack of paralytic poliomyelitis

(2) Dihydroergotoxine Mesylate Injection

60

Dihydrotachysterol...............................

Hypoparathyroidism

61

Dimethicone Aerosol Spray

Ileostomy or colostomy conditions

62

Dimethicone Creams............................

Use with surgical appliances

63

(1) Dioctyl Sodium Sulphosuccinate

Any disease or condition in a pensioner

(2) Dioctyl Sodium Sulphosuccinate with Danthron

64

Disodium Cromoglycate......................

With the written authority of the Director-General, the treatment of chronic intractable asthma

65

Droperidol...............................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

66

Epicillin....................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

67

Ethacrynic Acid.....................................

Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome

Fluid retention associated with other conditions and not responding to thiazides

68

Ethinyloestradiol Tablets, B.P.

Any disease or condition in a pensioner

Carcinoma of the breast post-menopausal

Carcinoma of the prostate

Hereditary telangiectasis

Premature menopause that is surgically induced

Turner’s syndrome

69

Ethionamide...........................................

Tuberculosis

70

Ethisterone Tablets, B.P.......................

Turner’s syndrome

71

Ethyloestrenol........................................

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

Osteomalacia following gastrectomy

72

Fludrocortisone Tablets, B.P.

Adrenal cortical hypoplasia including Addison’s disease

Total adrenalectomy

73

Fluorouracil Sodium.............................

Treatment in malignant neoplasia

74

Fluoxymesterone Tablets, B.P.

Eunuchism

Eunuchoidism Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Proven aplastic anaemias

75

(1) Fluphenazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Fluphenazine Tablets, B.P.

Major psychoses including—

(3) Fluphenazine Enanthate

Major organic psychoses

(4) Fluphenazine Decanoate

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

76

(1) Folic Acid, B.P.................................

Cystic Fibrosis

(2) Folic Acid Tablets, B.P. 5 mg

Proven folic acid deficiency

Sprue or the sprue-like syndrome

77

Folic Acid Tablets, B.P. 0.5 mg.

Cystic Fibrosis

Pregnancy

78

Framycetin Sulphate Injection

Sub-conjunctival injection in the treatment of serious ocular inflammation

79

Framycetin Sulphate Tablets

Bowel sterilization preparatory to major surgery

80

Frusemide Tablets, B.P.........................

Fluid retention associated with heart failure, cirrhosis of the liver or nephrotic syndrome

Fluid retention associated with other conditions and not responding to thiazides

81

Galactomin Formula No. 17

With the written authority of the Director-General—

Galactosaemia

Conditions needing an extreme restriction of lactose in the diet of a patient under the age of four years

82

Galactomin Formula No. 19

With the written authority of the Director-General, glucose-galactose malabsorption

83

Gentamicin Sulphate............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

84

Glucose Indicator—Blood...................

With the written authority of the Director-General, diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing

85

Goat’s Milk, Dehydrated.....................

With the written authority of the Director-General, cow’s milk allergy in children under the age of four years

86

Goat’s Milk, Whole (Sterilized)

With the written authority of the Director-General, cow’s milk allergy in children under the age of four years

87

(1) Griseofulvin, B.P.............................

With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination or Wood’s Light

(2) Griseofulvin Tablets, B.P.

  

88

Halibut Liver Oil Capsules..................

Any disease or condition in a pensioner

89

Haloperidol.............................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Major psychoses including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

90

Hydrocortisone Acetate Injection, B.P.

Intra-articular use

91

Hydrocortisone Sodium Succinate Injection, 100 mg.

Acute medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy

92

Hydrocortisone Sodium Succinate Injection, 250 mg. and 500 mg.

Any disease or condition in a patient receiving treatment in or at an approved hospital

93

Hydroxocobalamin Injection, B.P.

Pernicious anaemia and other proven Vitamin B-12 deficiencies

Post gastrectomy treatment

Sub-acute combined degeneration of the cord

Neuroblastoma

94

Hydroxyprogesterone Caproate

Carcinoma of the endometrium

Progesterone deficiency proved by hormonal assay, by lateral wall smear or by endometrial biopsy

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

95

Hydroxyurea

Any disease or condition in a patient receiving treatment in or at an approved hospital

96

Idoxuridine.............................................

Infections caused by Herpes Simplex Virus

97

Influenza Vaccine.................................

For prophylaxis of pensioners only

98

Insect Allergen Extract—Honey Bee

With the written authority of the Director-General, severe constitutional reaction to bee stings

99

Insect Allergen Extract—Jumper Ant

With the written authority of the Director-General, severe constitutional reaction to jumper ant stings

100

Insect Allergen Extract—Paper Wasp

With the written authority of the Director-General, severe constitutional reaction to wasp stings

101

Isoniazid Tablets, B.P...........................

Tuberculosis

102

Isoprenaline Hydrochloride Tablets, 30 mg.

Stokes-Adams Syndrome

103

Kanamycin Sulphate Injections

With the written authority of the Director-General—

Infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic

Septicaemia, including suspected septicaemia

104

Lactulose.................................................

Hepatic coma or pre-coma (chronic portosystemic encephalopathy)

105

Leucovorin..............................................

Antidote to folic acid antagonists

106

Levodopa................................................

With the written authority of the Director-General, treatment of Parkinson’s Disease

107

Lignocaine Injection, B.P.....................

Cardiac arrhythmias

108

Lincomycin Hydrochloride..................

Gram positive coccal infections where these cannot be safely and effectively treated with a penicillin

Osteomyelitis

109

Liothyronine Tablets, B.P....................

Myxoedema

110

Lithium Carbonate Tablets, B.P..........

With the written authority of the Director-General, manic depression

111

Locasol....................................................

With the written authority of the Director-General, Hypercalcaemia in children under the age of two years

112

Lofenalac................................................

With the written authority of the Director-General, phenylketonuria

113

Lypressin Nasal Spray..........................

Diabetes insipidus

114

Maphenide Acetate...............................

Any disease or condition in a patient receiving treatment in or at an approved hospital

115

Medroxyprogesterone Acetate Tablets, 2.5 mg.

Carcinoma of the endometrium

116

Medroxyprogesterone Acetate Tablets, 10 mg.

Carcinoma of the endometrium

Precocious puberty

117

Medroxyprogesterone Acetate Tablets, 100 mg.

Carcinoma of the breast

Carcinoma of the endometrium

Hypernephroma

118

Medroxyprogesterone Acetate Injections

Carcinoma of the endometrium

Hypernephroma

Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy

119

Melphalan...............................................

Treatment in malignant neoplasia

120

Mercaptopurine Tablets, B.P.

Allergic granulomatous angiitis

Lupus erythematosus

Nephrotic syndrome

Periarteritis (Nodosa)

Treatment in malignant neoplasia

121

(1) Methandienone Tablets, B.P.

With the written authority of the Director-General—

(2) Methenolone Acetate

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

122

Methicillin Sodium, B.P., for Injection

Proven or suspected staphylococcal septicaemia

123

(1) Methotrexate Tablets.....................

Treatment in malignant neoplasia

(2) Methotrexate Injections.................

Pemphigus vulgaris

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

124

Methylprednisolone Acetate Retention Enema

With the written authority of the Director-General—

Colitis, ulcerative, proven by sigmoidoscopy or radiological report

Proctitis, proven by sigmoidoscopy

125

Methylprednisolone Acetate Injection

Intra-articular use

126

(1) Methyltestosterone Tablets, B.P.

Carcinoma of the breast

Eunuchism

Eunuchoidism

(2) Methyltestosterone, B.P.

Klinefelter’s syndrome (seminiferous tubulo dysgenesis)

127

Methysergide Maleateot......................

Treatment of severe recalcitrant migraine where other treatment has failed

128

Metyrapone............................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

129

Minafen...................................................

With the written authority of the Director-General phenylketonuria

130

Morphine Sulphate, B.P. with Tacrine Tablets

Severe intractable pain

131

Mustine Hydrochloride Injection

Treatment in malignant neoplasia

132

Nalidixic Acid........................................

Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nalidixic acid or where the patient is sensitive to sulphonamides

133

Nandrolone Decanoate.........................

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

Severe osteoporosis due to proven pancreatitis

134

Nandrolone Hexoxyphenyl Propionate

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for patients on long-term treatment with corticosteroids

Intermittent use for corticosteroid-induced osteoporosis

135

Nandrolone Phenylpropionate Injection, B.P.

Carcinoma of the breast

With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis

136

Neomycin Sulphate Powder

With the written authority of the Director-General, use by inhalation in Cystic Fibrosis (mucoviscidosis)

137

Neomycin Tablets, B.P.........................

Bowel sterilization preparatory to major surgery

Encephalopathy, hepatic

Enteropathogenic E. coli infections in infants

138

Nicotinic Acid Tablets, B.P.

Any disease or condition in a pensioner

139

(1) Nitrofurantoin Tablets, B.P.

Urinary tract infections where sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides

(2) Nitrofurantoin Oral Suspension

140

Nitromin..................................................

Treatment of malignant neoplasia

141

Norethisterone Acetate, B.P.

Carcinoma of the breast

142

Norethisterone Tablets, B.P.

Endometriosis

Metropathia haemorrhagica

Precocious puberty

143

Nutramigen.............................................

With the written authority of the Director-General—

Cow’s milk allergy in children under the age of four years

Cystic Fibrosis (mucoviscidosis)

Galactosaemia

Lactose intolerance

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

144

Oxprenolol Hydrochloride Tablets

With the written authority of the Director-General—

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

145

Oxprenolol Hydrochloride Injection

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm, aortic

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

146

Oxycodone Pectinate.............................

Treatment in malignant neoplasia

147

Oxymetholone........................................

With the written authority of the Director-General—

Proven aplastic anaemias

Myelosclerosis

148

(1) Pancreatin, B.P.................................

Cystic Fibrosis (mucoviscidosis)

(2) Pancreatin Enzyme 4X U.S.N.F. XII

Following pancreatico-duodenectomy

Pancreatic steatorrhoea

(3) Pancrelipase

149

Paracetamol with Codeine Phosphate and Pentobarbitone Sodium

Any disease or condition in a pensioner

150

(1) Paraffin Liquid Emulsion

Any disease or condition in a pensioner

(2) Paraffin Liquid Emulsion with Phenolphthalein

151

Penicillamine...........................................

With the written authority of the Director-General—

Acute heavy metal intoxication

Cystinosis

Cystinuria with calculus formation

Haemoglobinuria, paroxysmal cold

Wilson’s disease (hepatolenticular degeneration)

152

(1) Pericyazine Mesylate

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Pericyazine

Major psychoses, including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

153

Phytomenadione Injection, 10 mg. per ml.

Antidote to anticoagulants

Haemorrhagic diathesis associated with malabsorption

154

Phytomenadione Injection, B.P., 1 mg. in 1 ml.

Antidote to anticoagulants

Haemorrhagic diathesis associated with malabsorption

Suspected cerebral trauma of the new born

Haemorrhagic disease of the new born

155

Pituitary, Posterior Lobe, Insufflation

Diabetes insipidus

156

Pizotifen Malate.....................................

The treatment of severe migraine in a patient whose attacks of migraine do not respond to treatment by other therapeutic agents

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

157

(1) PK AID I...........................................

With the written authority of the Director-General, phenylketonuria

(2) PK AID II..........................................

158

Plasma Subsititute (Polypeptide)

Any disease or condition in a patient receiving treatment in or at an approved hospital

159

Polyisobutylene......................................

Ileostomy or colostomy conditions

160

Polymyxin B. Sulphate Powder

With the written authority of the Director-General, use by inhalation in cystic fibrosis (mucoviscidosis)

161

Polyoestradiol Phosphate.....................

Carcinoma of the breast

Carcinoma of the prostate

162

Practolol Injection.................................

Dissecting aneurism, aortic

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

163

Practolol Tablets....................................

With the written authority of the Director-General—

Dissecting aneurysm, aortic

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

164

Prednisolone Sodium Phosphate Retention Enema and Suppository

With the written authority of the Director-General—

Ulcerative colitis proven by sigmoidoscopy or radiological report

Proctitis proven by sigmoidoscopy

165

(1) Prednisolone Acetate Injection

Intra-articular use

(2) Prednisolone Butyl Acetate Injection

166

Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.

Corneal grafts

Uveitis

167

Prednisolone Sodium Phosphate Injection, B.P.

Acute medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy

168

Prednisolone Sodium Succinate Injection

Acute medical or surgical crisis

Prophylactic therapy before, during and after surgical procedures for patients requiring or recently subjected to steroid therapy

169

Prindolol Injection

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

170

Prindolol Tablets........................

With the written authority of the Director-General—

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Initial treatment of severe hypertensive disease where the diastolic pressure is constantly above 130 mm. and the disease has not responded to other therapeutic agents except other beta-adrenergic receptor blocking agents

A second or subsequent course of treatment for severe hypertensive disease in patients whose condition responds to prindolol

171

Procarbazine Hydrochloride

Treatment in malignant neoplasia

172

(1) Prochlorperazine

Meniere’s Syndrome

(2) Prochlorperazine Tablets, B.P.

173

 

Progesterone..............................

 

Progesterone deficiency proven by hormonal assay, by lateral wall smear or by endometrial biopsy

174

Promethazine Theoclate Tablets, B.P.

Vomiting in pregnancy

175

Propranolol Injection, B.P...........

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

176

Propranolol Tablets, B.P.............

With the written authority of the Director-General—

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents

Serious arrhythmias

Thyrotoxicosis

Initial treatment of severe hypertensive disease where the diastolic pressure is constantly above 130 mm. and the disease has not responded to other therapeutic agents except other beta-adrenergic receptor blocking agents

A second or subsequent course of treatment for severe hypertensive disease in patients whose condition responds to propranolol

177

Proscillaridin..............................

Patients intolerant of oral forms of prepared digitalis, digoxin and lanatoside C

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

178

Prosobee..................................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

179

Pyrazinatnide..........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

180

Pyridoxine Hydrochloride Tablets

Homocystinuria

Radiation sickness

Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy

Sideroblastic (refractory) anaemia

Proven pyridoxine responsive anaemia

With the written authority of the Director-General, primary hyperoxaluria

181

Riboflavine Tablets...............................

Any disease or condition in a pensioner

182

Senna Fruit Extract (standardised)

Any disease or condition in a pensioner

183

Similac Isomil.........................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

184

Sobee........................................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

185

(1) Sodium Aminosalicylate Tablets, B.P.

Tuberculosis

(2) Sodium Aminosalicylate Injection

(3) Sodium Aminosalicylate Cachets

(4) Sodium Aminosalicylate Granules

(5) Sodium Aminosalicylate with Isoniazid, B.P.

186

(1) Sodium Fusidate..............................

With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence

(2) Diethanolamine Fusidate

187

Soyalac....................................................

With the written authority of the Director-General—

Galactosaemia

Homocystinuria

Lactose intolerance

Milk allergy in children under the age of four years

188

Spectinomycin Dihydrochloride Pentahydrate

Gonorrhoea

 

189

Spironolactone Tablets, B.P.

With the written authority of the Director-General—

To supplement other diuretics when these have proved inadequate

Myasthenia gravis

Primary hyperaldosteronism

190

Stanolone................................................

Carcinoma of the breast

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

191

Stanozolol...............................................

With the written authority of the Director-General—

Intermittent use for corticosteroid-induced osteoporosis

Intermittent use for patients on long-term treatment with corticosteroids

192

Stilboestrol Diphosphate......................

Carcinoma of the prostate

193

Streptokinase..........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

194

Sulphasalazine.......................................

Ulcerative colitis

195

(1) Surgical Cement..............................

Ileostomy or colostomy conditions

(2) Surgical Cement Solvent...............

For use with surgical appliances

196

(1) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Eunuchoidism

Eunuchism

Klinefelter’s syndrome (seminiferous tubule dysgenesis)

(2) Testosterone Propionate, B.P. with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

Carcinoma of the breast

(3) Testosterone Implants, B.P.

(4) Testosterone Enanthate

(5) Testosterone Propionate Injection, B.P.

197

Tetanus Antitoxin, B.P. (Bovine)

Patients who have previously received an injection of equine serum

198

Thiamine Hydrochloride Tablets, B.P.

Any disease or condition in a pensioner

199

Thiethylperazine Maleate Tablets and Suppositories

Radiation sickness

Nausea resulting from cytotoxic therapy

200

(1) Thioridazine.....................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Thioridazine Tablets, B.P.

Major psychoses including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Severe conduct disorders of children

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

201

Thyrotrophin..........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

202

Tragacanth, Indian (Gum Karaya)

Ileostomy or colostomy conditions

203

Triamcinolone Acetonide Injection

With the written authority of the Director-General, treatment of keloids

204

 

(1) Trifluoperazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Trifluoperazine Tablets, B.P.

Major psychoses including—

Major organic psychoses

Manic psychoses

Paranoid states

Schizophrenia

Hereditary chorea (Huntington’s)

Malignant neoplasia (late stage)

Radiation sickness

205

Triglyde....................................................

With the written authority of the Director-General, proven malabsorption

Fifth Schedule—continued

First Column

Second Column

Third Column

Item No.

Pharmaceutical Benefit

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

206

Trimethoprim with Sulphamethoxazole

Infections by susceptible organisms where these cannot be safely and effectively treated with other sulphonamides, oral forms of benzyl penicillin, phenoxymethylpenicillin or phenethicillin

Urinary tract infections where other sulphonamide treatment has proved ineffective and where positive bacteriological evidence shows the organism to be sensitive to trimethoprim with sulphamethoxazole

Ocular surgery

207

(1) Vinblastine Sulphate.......................

Treatment in malignant neoplasia

(2) Vincristine Sulphate

208

Vinyl Pyrrolidone and Vinyl Acetate with Benzocaine Aerosol Spray

Ileostomy or colostomy conditions

209

(1) Viomycin Sulphate.........................

Tuberculosis

(2) Viomycin Sulphate Injection, B.P.

210

Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D Tablets and Capsules

Any disease or condition in a pensioner

                  

Printed by Anthority by the Government Printer of the Commonwealth of Australia

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0